Adult Primary Care (APC) 2019/2020

Objectives

Adult Primary Care (APC) is a comprehensive clinical decision-support approach for adults aged 18 years and over in South Africa, designed to help healthcare practitioners provide sound, continuous and person-centred primary care.[1]It prioritises respect for patients’ concerns and choices, trusting and empathetic clinical relationships, follow-up for chronic conditions, links to community resources and continuity of care.[1]

• Provide integrated assessment and management across general health, emergencies, symptoms, tuberculosis, HIV, asthma and chronic obstructive pulmonary disease, cardiovascular disease, diabetes, mental health, epilepsy, musculoskeletal conditions and palliative care.[1]
• Promote prevention through healthy lifestyle counselling, vaccination, sexual and reproductive health services, tobacco, alcohol and drug-use interventions, screening, cardiovascular risk assessment and early identification of urgent conditions.[2][3][4][5][6]
• Strengthen chronic-care outcomes through routine monitoring, adherence support, treatment adjustment, risk-factor management, community support and timely referral for complications or specialist care.[7][8][9][10]
• Support maternal, antenatal, postnatal and infant care through repeated assessment, prevention of mother-to-child transmission of HIV, family planning, immunisation, feeding support and escalation for pregnancy or postnatal complications.[11][12][13][14]
• Improve clinical content through updated algorithms, checklists and guidance, including HIV, maternal care, rifampicin-resistant tuberculosis, mental health, palliative care and symptom management.[15]

The supplied material does not set quantified document-level targets, a time-bound national results framework or a broader policy mission beyond APC’s clinical purpose and areas of care.[1][15]

Implementation

APC is implemented within Integrated Clinical Services Management and the Ideal Clinic Realisation and Maintenance initiative, using concise on-site training based on simulated case scenarios.[1]Consultations are structured around general health, symptoms and chronic conditions, using clinical algorithms, colour-coded routine-care pages, referral arrows and an Assess, Advise and Treat framework.[15][16]

• Deliver person-centred consultations by eliciting concerns and expectations, explaining benefits and harms of interventions, agreeing practical self-management goals and supporting healthy behaviour change.[3][17][18]
• Apply scope-appropriate prescribing by distinguishing medicines that doctors or nurses may prescribe, medicines initiated by doctors but continued by nurses, and medicines restricted to doctors.[16][19]
• Use approved formularies and medicines-information services when treatment choices, dosing, interactions, adverse effects or medicine availability are uncertain.[19]
• Provide differentiated continuity of care, including Central Chronic Medicines Dispensing and Distribution registration for stable chronic patients, six-month repeat prescriptions, monthly collection at selected collection points and six-monthly facility review.[19]
• Use triage and referral pathways to give urgent attention to serious symptoms and abnormal clinical findings, while maintaining routine measurements, screening and condition-specific follow-up for patients without immediate danger.[19][20][21]
• Coordinate care among doctors, nurses, pharmacy staff, counsellors, community health workers, specialists, social workers, therapists, hospitals, advisory committees and community or helpline services where indicated.[8][22][23][24][25]
• Support quality improvement through collaboration between the University of Cape Town Lung Institute Knowledge Translation Unit, the National Department of Health, the National Essential Medicines List Committee, Clinical Programmes, clinicians, policymakers and end-users.[16]

Operational monitoring is mainly embedded in clinical care: providers record assessments, monitor symptoms, treatment response, adherence, side effects, laboratory results and referral outcomes at specified intervals for conditions such as tuberculosis, HIV, diabetes, hypertension, pregnancy and chronic respiratory disease.[7][26][10][27][28]Adverse drug reactions are reported through the specified forms and pharmacovigilance channels.[19][29]APC content is refined through development, testing, consultation and end-user feedback, including feedback submitted to the Knowledge Translation Unit website.[15][16]

The material identifies development funding from the National Department of Health and the United States President’s Emergency Plan for AIDS Relief through implementing agencies of the United States Agency for International Development and the Centers for Disease Control and Prevention.[16]It does not specify a quantified budget, allocations, unit costs, financing gap, formal programme-level indicators, reporting cycles, surveillance governance or a comprehensive accountability framework.[16]

Monitoring & Evaluation

Monitoring is predominantly embedded in patient-level clinical care rather than a single programme-wide monitoring and evaluation system. Adult Primary Care is refined through clinician, policymaker and end-user consultation and feedback, including feedback submitted through the Knowledge Translation Unit website.[15][16]Across the supplied guidance, formal programme indicators, routine reporting cycles, surveillance governance, evaluation methods and overarching accountability arrangements are generally not specified.[15][16]

• Monitor routine care through repeated assessment of symptoms, vital signs, treatment adherence, side effects, medicine interactions, mental health, substance use, sexual health and referral needs at clinically defined intervals.[19][29][30]
• Record clinical information in patient records, condition-specific cards and registers, including tuberculosis diagnosis, test results, adherence, treatment interruption and final treatment outcomes.[7][31]
• Report suspected adverse drug reactions through designated forms, clinic pharmacies, the South African Health Products Regulatory Authority, pharmacists or the National Pharmacovigilance Centre.[19][29]
• Use routine assessment schedules for pregnancy, hypertension, diabetes, cardiovascular disease risk, contraception, HIV, tuberculosis and chronic respiratory disease to trigger treatment changes or referral.[20][21][26][32][33][11][28]

Tuberculosis care has the most explicit documentation and outcome-monitoring mechanisms. Patients are registered at diagnosis and entered into the electronic tuberculosis register, while sputum, culture, line-probe assay and treatment-outcome results are recorded.[7][31]Drug-sensitive tuberculosis monitoring includes symptom, adherence, side-effect, weight and body mass index assessment at every visit; week-seven smear testing to inform possible regimen changes; and week-23 smear results to determine outcome.[7][31]For rifampicin-resistant tuberculosis, facilities should update registers with sputum results at every visit, review clinical status and adherence at each visit, and conduct scheduled microscopy, culture, drug-susceptibility and safety testing.[34][35]

HIV care similarly relies on scheduled clinical and laboratory follow-up. Providers monitor attendance, adherence, symptoms including tuberculosis symptoms, adverse effects, depression, alcohol or drug use and sexual health at every visit.[29][30]Viral load is monitored at six months, one year and annually thereafter, with additional testing during pregnancy, breastfeeding or rifampicin-resistant tuberculosis treatment; CD4 monitoring and regimen-specific renal, haematological, lipid and liver-safety tests are scheduled according to treatment status and medicines.[26]Post-exposure prophylaxis follow-up occurs within three days, at two weeks, six weeks and four months, with adherence, side effects, HIV status and relevant hepatitis, renal and haematological results reviewed.[36]

Non-communicable disease and chronic-care monitoring is also clinically specific. Cardiovascular risk is calculated over 10 years and categorised as below 10%, 10–20% or above 20%, with reassessment frequency linked to risk and treatment status.[37][38][39]Diabetes care includes routine blood-pressure, eye, foot, urine, renal-function, lipid and glucose or glycated-haemoglobin assessment, with intensified monitoring after treatment changes.[10]Asthma and chronic obstructive pulmonary disease monitoring uses symptom control, inhaler technique, adherence, peak expiratory flow rate and scheduled reviews, although no population-level reporting framework is specified.[32][33][40][41]

Maternal, newborn and reproductive-health guidance provides repeated clinical monitoring points. Antenatal care is scheduled at booking and seven follow-up visits, with monitoring of blood pressure, urine, haemoglobin, infection risks, HIV status and viral load, fetal growth, fetal movement and mental health.[11][28]Postnatal review of mother and baby is scheduled at six hours, six days and six weeks, with HIV-exposed infants tested at birth, 10 weeks, six months, 18 months and six weeks after breastfeeding ends.[13][42]Cervical screening intervals distinguish between HIV-negative patients, screened three times from age 30 at 10-year intervals, and patients living with HIV, screened every three years from diagnosis.[43][44]

Accountability mechanisms are chiefly clinical escalation, specialist consultation and documentation. The guidance directs referral or discussion when treatment response is poor, safety thresholds are breached, diagnostic uncertainty persists or severe presentations occur.[45][46][47][48]Specific formal accountability requirements appear in limited areas, including completion of forms and registers for rape or sexual-assault care, and recording and reporting required under Mental Health Care Act authorisations or orders.[49][50]No consolidated framework defines national performance targets, data-quality processes, independent evaluation, public reporting or institutional accountability for APC implementation.[15][16]

Costing & Financing

Costing and financing information is very limited. Development of Adult Primary Care and its successive iterations was funded by the National Department of Health and by the President’s Emergency Plan for AIDS Relief through implementing agencies of the United States Agency for International Development and the Centers for Disease Control and Prevention.[16]

• Provide no quantified budget, expenditure, unit cost, allocation, funding gap, resource-mobilisation target or economic assumption for APC development or implementation.[16]
• Specify clinical resources, medicines, diagnostics, monitoring equipment, training, referral, helplines and community support in many care pathways, but provide no associated financial values.[51][52][40][41][53]
• Leave treatment costs, facility costs and financing arrangements unspecified for tuberculosis, HIV, maternal care, non-communicable disease management, mental health and palliative care.[54][7][31][9][55][13][42][56][57][58]

Consequently, the supplied material cannot support assessment of affordability, fiscal sustainability, cost-effectiveness, budget adequacy, funding gaps or the financial responsibilities of implementing institutions.[16][54][7][31]